
Patrick Lally
April 12, 2022
Patrick Lally is a partner at Petrichor Healthcare Capital Management, a life sciences-focused investment firm. Prior to joining Petrichor, Mr. Lally was a vice president at OrbiMed Advisors in their healthcare special situations and structured finance practice. Before OrbiMed, Mr. Lally was a healthcare investor in the Drawbridge Special Opportunities Fund at Fortress Investment Group. Mr. Lally holds an M.B.A. from The Wharton School at the University of Pennsylvania and an A.B. in Molecular Biology from Princeton University.
Recent Articles
CorneaGen Advances Next Generation of DSEK Surgery Innovation
New FDA approved, pre-loaded cornea graft insertion device maximizes efficiency...
READ MOREASCRS 2022 – Washington, D.C.
This meeting, focused on therapeutic, surgical, and administrative topics directly...
READ MOREZiemer USA Announces Partnership with CorneaGen
Ziemer USA, a wholly owned subsidiary of Switzerland-based Ziemer AG,...
READ MORE